Successful treatment of electrical storm with oral quinidine in Brugada syndrome

Italian Heart Journal

Volumn 6, Issue 7, 2005, Pages 601-602

  Bettiol, Katia ^a   Gianfranchi, Lorella ^a   Scarfò, Salvatore ^a   Pacchioni, Federico ^a   Pedaci, Mario ^a   Alboni, Paolo ^a  

^a Civic Hospital   (Italy)

Author keywords

Implantable defibrillators; Ventricular fibrillation

Indexed keywords

ANTIARRHYTHMIC AGENT; QUINIDINE;

ARTICLE; CASE REPORT; FEMALE; HEART BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HUMAN; MIDDLE AGED; ORAL DRUG ADMINISTRATION; REMISSION; SYNDROME;

ADMINISTRATION, ORAL; ANTI-ARRHYTHMIA AGENTS; BUNDLE-BRANCH BLOCK; FEMALE; HUMANS; MIDDLE AGED; QUINIDINE; REMISSION INDUCTION; SYNDROME; VENTRICULAR FIBRILLATION;

EID: 33645562683     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20:1391-6.
2. Alings M, Wilde A. Brugada syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999; 99: 666-73.
3. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 2000; 102: 2509-15.
4. Antzelevitch C, Brugada P, Brugada J, et al. The Brugada syndrome. In: Camm AJ, ed. Clinical approaches to tachy-arrhythmias. Armonk, NY: Futura Publishing Company, 1999: 50-66.
5. Shimuzu W, Kamakura S. Catecholamines in children with congenital long QT syndrome and Brugada syndrome. J Electrocardiol 2001; 34 (Suppl): 173-5.
6. Tanaka H, Kinoshita O, Uchikawa S, et al. Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin Electrophysiol 2001; 24 (Part 1): 1293-4.
7. Alings M, Dekker L, Sadee A, Wilde A. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol 2001; 24 (Part 1): 1420-2.
8. Suzuky H, Torigoe K, Numata O, Yazakis S. Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11: 1277-80.
9. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10: 1301-12.
10. Hermida JS, Denjoy I, Clerc J, et al. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 2004; 43: 1853-60.
11. Mok NS, Chan NY, Chin AC. Successful use of quinidine in treatment of electrical storm in Brugada syndrome. Pacing Clin Electrophysiol 2004; 27 (Part 1): 821-3.
12. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100: 1660-6.